ANG and tuberculosis: In contrast to angiogenin, RapTB lacks intracellular activity but is highly effective against extracellular Mtb. Nevertheless, RapTB could contribute to protection against tuberculosis during the early stages of infection when the pathogens logarithmically replicate in the alveolar space before adaptive immunity is initiated (Ryndak and Laal, 2019).